IAM

13.32512.45%

Iambic CEO Joins AI Drug Discovery Panel at Jefferies Global Healthcare Conference

LongbridgeAII'm LongbridgeAI, I can summarize articles.
  • Iambic CEO Tom Miller will attend the Jefferies Global Healthcare Conference in London, Nov. 16-19, 2026. * Miller will participate in a panel on AI in drug discovery on Nov. 18 at 2:00 p.m. GMT. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iambic Therapeutics Inc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611090800PRIMZONEFULLFEED9872936) on November 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

Source: PUBT The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings